SRTS
Sensus Healthcare, Inc. · Healthcare · Market cap $47.1M
Insiders bought $564K net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Aug 31, 2026
Insider Buying
$729K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Aug 31, 2026
Sachetta Eric
Sensus Healthcare, Inc. (SRTS) has 17 SEC Form 4 filings (24 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 31, 2026.
Inside the rolling window, 3 insiders at Sensus Healthcare, Inc. reported 15 open-market purchases totaling $729K and no open-market sales. The most active filer is Director Sachetta Eric with 11 filings. Insiders have net bought $569K over the trailing 6 months. The most recent open-market filing is a purchase of 37,537 shares by Director Sachetta Eric, dated Aug 28, 2026, worth $129K.
- Industry:Medical - Devices
- CEO:Joseph C. Sardano
- Employees:60
- HQ:Boca Raton, FL, US
- IPO:2016-07-26
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Purchase | 37,537 | $129K | Aug 31 | -19.2% | SEC ↗ | |
| Director | Purchase | 27,304 | $97K | Aug 31 | -19.2% | SEC ↗ | |
| Director | Purchase | 9,708 | $32K | Aug 28 | -18.8% | SEC ↗ | |
| Director | Purchase | 10,925 | $35K | Aug 28 | -18.8% | SEC ↗ | |
| Director | Purchase | 34,697 | $113K | Aug 25 | -14.9% | SEC ↗ | |
Sardano Joseph CFirst in 9 months | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $60K | Aug 24 | -18.1% | SEC ↗ |
Sachetta EricFirst in 3 months | Director | Purchase | 24,000 | $75K | Aug 24 | -18.1% | SEC ↗ |
Sachetta EricFirst in 3 months | Director | Purchase | 7,000 | $23K | Aug 24 | -18.1% | SEC ↗ |
| Director | Purchase | 1,500 | $5K | May 12 | -15.1% | SEC ↗ | |
Sachetta EricFirst in 3 months | Director | Purchase | 2,000 | $8K | Feb 26 | -28.9% | SEC ↗ |
| Director | Purchase | 7,000 | $28K | Nov 21 | — | SEC ↗ | |
Sachetta EricFirst filing | Director | Purchase | 2,500 | $11K | Nov 20 | — | SEC ↗ |
| PRESIDENT AND GENERAL COUNSEL | Purchase | 1,000 | $4K | Nov 19 | — | SEC ↗ | |
Sardano Joseph CFirst filing | CHIEF EXECUTIVE OFFICER | Purchase | 25,000 | $101K | Nov 19 | — | SEC ↗ |
| PRESIDENT AND GENERAL COUNSEL | Purchase | 2,234 | $10K | Nov 18 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does SRTS have?
Sensus Healthcare, Inc. (SRTS) has 17 SEC Form 4 filings (24 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Aug 31, 2026.
When was the most recent SEC Form 4 filing for SRTS?
The most recent Form 4 filing for SRTS on Tracefour is dated Aug 31, 2026.
Who is the most active insider at SRTS?
The most active SEC Form 4 filer at SRTS in the rolling window is Director Sachetta Eric, with 11 filings.
What is the net insider flow at SRTS over the last 6 months?
Over the trailing 180 days, insiders at SRTS have net bought $569K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at SRTS in the current window?
Inside the rolling window, insiders at SRTS bought $729K and sold $0 based on SEC Form 4 filings.
Can I get alerts for SRTS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Sensus Healthcare, Inc. (SRTS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Sensus Healthcare, Inc. is in the Healthcare sector.